Literature DB >> 10073982

Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship.

Z Zhang1, K Cianflone, A D Sniderman.   

Abstract

Our understanding of the factors that regulate the secretion of apoB100 lipoproteins remains incomplete with considerable debate as to the role, if any, for cholesterol ester in this process. This study examines this issue in primary cultures of hamster hepatocytes, a species in which both cholesterol and apoB100 metabolism are very similar to man. Addition of oleate to medium increased the mass of triglyceride and cholesterol ester within the hepatocyte and also increased the secretion of triglycerides, cholesterol ester, and apoB100 into the medium. Next, the responses of hamster hepatocytes to addition of either an HMG-CoA reductase inhibitor (lovastatin) or an acyl-CoA cholesterol acyltransferase inhibitor (58-035) to the medium, with or without added oleate, were determined. Effects of either agent were only evident in the oleate-supplemented medium in which cholesterol ester mass had been increased above basal. If oleate was not added to the medium, neither agent reduced apoB100 secretion; equally important, over the 24-hour incubation, neither agent, at the concentration used, produced any detectable change in intracellular cholesterol ester mass. However, in contrast to the estimates of mass, which were unchanged, under the same conditions radioisotopic estimates of cholesterol ester synthesis were markedly reduced. Any conclusion as to the relation of cholesterol ester mass to apoB100 secretion would therefore depend on which of the 2 methods was used. Overall, the data indicate a close correlation between the mass of cholesterol ester within the hepatocyte and apoB100 secretion from it and they go far to explain previous apparently contradictory data as to this relation. More importantly, though, taken with other available data, they indicate that the primary response of the liver to increased delivery of lipid is increased secretion rather than decreased uptake. These results point, therefore, to a hierarchy of hepatic responses to increased flux of fatty acids and increased synthesis of cholesterol that in turn suggests a more dynamic model of cholesterol homeostasis in the liver than has been appreciated in the past.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073982     DOI: 10.1161/01.atv.19.3.743

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster.

Authors:  Jaime L Lecker; Nirupa R Matthan; Jeffrey T Billheimer; Daniel J Rader; Alice H Lichtenstein
Journal:  Metabolism       Date:  2010-03-02       Impact factor: 8.694

Review 2.  Mechanism of action of niacin on lipoprotein metabolism.

Authors:  V S Kamanna; M L Kashyap
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.967

3.  Changes in cholesterol homeostasis modify the response of F1B hamsters to dietary very long chain n-3 and n-6 polyunsaturated fatty acids.

Authors:  Jaime L Lecker; Nirupa R Matthan; Jeffrey T Billheimer; Daniel J Rader; Alice H Lichtenstein
Journal:  Lipids Health Dis       Date:  2011-10-21       Impact factor: 3.876

4.  Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.

Authors:  Robert Scott Kiss; Allan Sniderman
Journal:  J Biomed Res       Date:  2017-01-19

5.  Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models.

Authors:  Sridhar Radhakrishnan; Steven F Yeung; Jia-Yu Ke; Maísa M Antunes; Michael A Pellizzon
Journal:  Curr Dev Nutr       Date:  2021-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.